On April 10th, Dr. Stephen Ansell of Mayo Clinic and Dr. Jorge Castillo of Dana-Farber Cancer Institute will be discussing “Progress in the Treatment of WM”
Shirley Ganse and Ronald Branscome are the newest members of the IWMF Board. Shirley’s writing skills and Ron’s non-profit experience will be of great benefit to all WMers.
Impressive response to call for entering quality of life data in WM registry, WhiMSICAL. Only 50 more respondents needed for data submission to major lymphoma conference.
Ryan was a marathon runner when diagnosed in 2010 at the age of 35. He joined the IWMF Chicago Support Group and found the help he needed from others who understood.
US WM patients currently in treatment, scheduled to start treatment, or being monitored by a doctor are eligible for a one-time $100 payment from an LLS support program.
Dr. Herbert Eradat’s (UCLA) presentation at the 2018 LRF Ed Forum, “WM: An Overview and Update on Advances and Novel Treatments,” is now available for viewing online.
The Mayo Clinic is holding a special patient event on March 16, 2019 to honor Dr. Kyle. Come and hear the latest on WM, including a presentation from the legendary Dr. Kyle.
Stephen was diagnosed in 1998 at the age of 63 and treated sequentially with 4 different drugs over 3 1/2 years. He’s been on watch and wait since his last treatment in 2001.
The LLS recently increased the co-pay assistance amount available for US WM patients to $7,500 to help defray medical costs.
The WhiMSICAL patient registry has a new set of questions that will enable researchers to map quality of life (QoL) data to treatments.